Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_assertion type Assertion NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_head.
- NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_assertion description "[These results suggest that one of the mechanisms of action of brefelamide is assumed to be inhibition of phosphorylation of ERK through a reduction of EGF receptor activity in 1321N1 human astrocytoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_provenance.
- NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_assertion evidence source_evidence_literature NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_provenance.
- NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_assertion SIO_000772 19559020 NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_provenance.
- NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_assertion wasDerivedFrom befree-2016 NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_provenance.
- NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_assertion wasGeneratedBy ECO_0000203 NP747779.RA8LzrLsjMWP6-kZBPxUlTC5V40q_IncEYFYpYAjl6gaM130_provenance.